Seems Pfizer has been working on how to avoid the disadvantages of HIV drug ritonavir in Paxlovid that doesn't treat SARS-CoV-2 but causes the severe adverse reactions to other medications that patients are taking and gives the drug the metallic taste that many hate.
With the only alternative to Paxlovid, Merck's Lagevrio being less than 30% effective as a treatment and since 2023 not recommended by WHO, FDA and EMA, I guess Pfizer was aware regulators around the world were in a bind. As many people were now unable to have an effective treatment for coronavirus, antiviral nasal sprays like Viraleze might get approved as a Govt sponsored treatments ...
So just as TGA and the Health Minister might have needed Viraleze on the PBS - Pfizer is aiming for a new profitable covid treatment with escalated approval.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)